Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Deep Genomics

Deep Genomics
2015 FOUNDED
PRIVATE STATUS
31-40 EMPLOYEES
Series A LATEST DEAL TYPE
$13M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of an integrated genetic computational system designed to interpret genetic variation. The company's integrated genetic computational system alters crucial cellular processes, including transcription, splicing, polyadenylation and translation, leading to effective therapies, enabling researchers to classify, prioritize, interpret and link genetic variants, whether natural or therapeutic.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Software
Primary Office
  • MaRS Centre, Heritage Building
  • Suite 320
  • Toronto, Ontario M5G 1L7
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Deep Genomics’s full profile, request a free trial.

Deep Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 14-Aug-2017 $13M 000.00 Completed Startup
2. Early Stage VC 18-Nov-2015 00.00 00.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Deep Genomics Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inscripta Venture Capital-Backed Boulder, CO 00000 00000000000 00000
000000000 00000000 Venture Capital-Backed San Diego, CA 0 000.00 00000000000 000.00
000 000000 Venture Capital-Backed Paris, France 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed New York, NY 0 00000 0000000000 00000
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Deep Genomics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0
11.2 Capital Venture Capital Minority 000 0000 000000 0
Bloomberg Beta Corporate Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
The UTEST Program Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Deep Genomics Executive Team (2)

Name Title Board
Seat
Contact
Info
Brendan Frey Ph.D Co-Founder, Chief Executive Officer & President

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »